OIG Cites Fraud, Waste and Abuse Concerns with Skin Substitutesย 

compliance risk for OIG skin sub

Many compliance professionals rely on HHS OIG focus areas as they perform risk assessments and plan subsequent auditing and monitoring activities. In November 2024, the OIG added an item to their Work Plan describing their intention to review Medicare Part B payments for skin substitutes.ย ย 

This blog explores the implications for compliance and what health systems need to be aware of.ย ย 

Continue reading

Three Strategies to Align Compliance with Revenue Cycleย 

align compliance with revenue cycle

The revenue cycle is the process that starts with a patient’s initial appointment and ends with full payment for services.โ€ฏIt encompasses all the administrative and clinical functions that contribute to collecting patient service revenue.โ€ฏ For healthcare organizations that provide services to patients, the revenue cycle is the organization’s financial lifeblood.ย 

Continue reading

What Happens When Integrity and Accountability Fail: Lessons for Compliance Professionalsย 

“The U.S. opioid epidemic holds important lessons for compliance professionals. This public health crisis is characterized by the widespread misuse of opioid drugs, leading to addiction, overdose deaths and a profound social and economic toll.ย ย 

This epidemic has evolved over the past few decades, and while there are many contributing factors, the role of pharmaceutical companies, particularly in the early stages, is widely seen as a critical element.”

Continue reading

The Cost of Non-Complianceย in Healthcare

cost of non-compliance shawn degroot

โ€œThe cost of non-compliance in healthcare extends far beyond fines and penalties. It encompasses legal fees, reputational damage, operational disruptions, and more. Investing in compliance is not just a legal obligationโ€”it is a critical component of a healthcare organizationโ€™s operational excellence and commitment to patient care.โ€

Continue reading